Patents by Inventor Devender Satsangi Singh Sandhu

Devender Satsangi Singh Sandhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8802383
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: August 12, 2014
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Devender Satsangi Singh Sandhu, Corey Lovitt, Artur Pedyczak, Scott Gallichan, Laszlo Radvanyi
  • Publication number: 20120295275
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Application
    Filed: May 16, 2012
    Publication date: November 22, 2012
    Applicant: Sanofi Pasteur, Ltd.
    Inventors: Neil Berinstein, Devender Satsangi Singh Sandhu, Corey Lovitt, Artur Pedyczak, Scott Gallichan, Laszlo Radvanyi